Results 191 to 200 of about 2,725,444 (278)

Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy. [PDF]

open access: yesJ Neurol
Dobelmann V   +10 more
europepmc   +1 more source

Risdiplam: therapeutic effects and tolerability in a small cohort of 6 adult type 2 and type 3 SMA patients. [PDF]

open access: yesOrphanet J Rare Dis
Severa G   +6 more
europepmc   +1 more source

Spinal muscular atrophy in an upper-middle-income nation before the advent of reimbursed disease-modifying therapies. [PDF]

open access: yesBMJ Paediatr Open
Sakpichaisakul K   +6 more
europepmc   +1 more source

Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen. [PDF]

open access: yesJ Neurol
Cebulla G   +9 more
europepmc   +1 more source

Profiling neuroinflammatory markers and response to nusinersen in paediatric spinal muscular atrophy. [PDF]

open access: yesSci Rep
Zhang Q   +8 more
europepmc   +1 more source

Neurological hospitalisations in childhood cancer survivors treated before 2001: findings from the French Childhood Cancer Survivor Study cohort. [PDF]

open access: yesBMC Neurol
Rajaonera D   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy